Filing Details
- Accession Number:
- 0001012975-15-000682
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-23 11:04:32
- Reporting Period:
- 2015-09-21
- Filing Date:
- 2015-09-23
- Accepted Time:
- 2015-09-23 11:04:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1138776 | Medgenics Inc. | MDGN | Biological Products, (No Disgnostic Substances) (2836) | 980217544 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
905536 | Isaac Blech | 1271 Avenue Of The Americas, 16Th Floor New York NY 10020 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-09-21 | 230,357 | $4.10 | 1,875,828 | No | 4 | X | Indirect | By Trust |
Common Stock | Disposition | 2015-09-21 | 94,825 | $9.96 | 1,781,003 | No | 4 | S | Indirect | By Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | X | Indirect | By Trust |
No | 4 | S | Indirect | By Trust |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrant (right to buy) | Disposition | 2015-09-21 | 230,357 | $0.00 | 230,357 | $4.10 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2010-09-22 | 2015-09-22 | No | 4 | X | Indirect |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 21,000 | Direct |
Footnotes
- On September 21, 2015, the reporting person exercised a warrant to purchase 230,357 shares of Common Stock for $4.10 per share. The reporting person paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 94,825 of the warrant shares to pay the exercise price and issuing to the reporting person of the remaining 135,532 shares.